TY  - GEN
AU  - Czuczman,M S
AU  - Grillo-López,A J
AU  - White,C A
AU  - Saleh,M
AU  - Gordon,L
AU  - LoBuglio,A F
AU  - Jonas,C
AU  - Klippenstein,D
AU  - Dallaire,B
AU  - Varns,C
TI  - Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
SN  - 0732-183X
PY  - 1999///0903
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Immunoglobulins
KW  - analysis
KW  - Lymphoma, B-Cell
KW  - genetics
KW  - Lymphoma, Non-Hodgkin
KW  - Male
KW  - Middle Aged
KW  - Polymerase Chain Reaction
KW  - Prednisone
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Rituximab
KW  - Translocation, Genetic
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.1999.17.1.268
ER  -